Experts see the research as a major development in the fight against a disease that affects around 350,000 people in the UK.The drug, rember, slows progression of Alzheimer's by as much as 81%, a British-led study found.
People taking it f [...]
Posted On : Jul, 30 2008 | Comments : 0